During a Senate hearing, concerns were raised over mifepristone, a medication used in abortions, following remarks from U.S. Health Secretary Robert F. Kennedy Jr. Senator Josh Hawley underscored the urgency for a review of the drug, citing recent data. Despite Hawley's claims, public health scientist Ushma Upadhyay criticized the reliance on what she described as 'junk science', asserting the safety of mifepristone through her research, which indicates a very low rate of serious adverse events. Kennedy acknowledged the need for a thorough review by the FDA.
In one study of Upadhyay's studies, 'among 11,000 medication abortions, less than a third of one percent (0.3%) had a serious adverse event,' the expert noted.
Ushma Upadhyay criticized Hawley, stating he is 'pointing to new junk science' to motivate the review of mifepristone, asserting the existing science shows it is safe.
Kennedy described the data cited by Hawley as 'alarming,' suggesting that 'the label should be changed' and confirming a complete review request to the FDA.
Hawley questioned Kennedy's commitment to a thorough review of mifepristone, emphasizing the pressing need for reconsideration based on new data.
Collection
[
|
...
]